Skip to main content
Figure 1 | Trials

Figure 1

From: Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study

Figure 1

Participant flow diagram. Vaccination groups are: 1xH5N1-AS, single dose of the AS03A-adjuvanted vaccine; 1xH5N1, single dose of the non-adjuvanted vaccine; 2xH5N1-AS, double dose of the AS03A-adjuvanted vaccine; 2xH5N1, double dose of the non-adjuvanted vaccine. ATP, according-to-protocol; M, month; N, number of participants in the specified group; n, number of participants with the specified reason for elimination.

Back to article page